Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Figley

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Opinion in Neurobiology|April 21, 2020
The SARM1 axon degeneration pathway: control of the NAD<sup>+</sup> metabolome regulates axon survival in health and diseaseMatthew D Figley, Aaron DiAntonio
Rare Diseases (Austin, Tex.)|July 9, 2014
Yeast genetic screen reveals novel therapeutic strategy for ALSMatthew D Figley, Aaron D Gitler
Current Biology : CB|August 22, 2015
Neurodegeneration: A Leg Up on TDP-43Matthew D Figley, Aaron D Gitler
Frontiers in Immunology|October 11, 2021
The SARM1 TIR NADase: Mechanistic Similarities to Bacterial Phage Defense and Toxin-Antitoxin SystemsAaron DiAntonio, Jeffrey Milbrandt, Matthew D Figley
Neurobiology of Aging|November 26, 2013
Evaluating noncoding nucleotide repeat expansions in amyotrophic lateral sclerosisMatthew D Figley, Anna Thomas, Aaron D Gitler
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 13, 2014
Profilin 1 associates with stress granules and ALS-linked mutations alter stress granule dynamicsMatthew D Figley, Gregor Bieri, Regina-Maria Kolaitis, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2021
Multiple domain interfaces mediate SARM1 autoinhibitionChen Shen, Mihir Vohra, Pengfei Zhang, et al.
Experimental Neurology|February 23, 2020
cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axonsYo Sasaki, Thomas M Engber, Robert O Hughes, et al.
Cell Reports|October 23, 2021
Neurotoxins subvert the allosteric activation mechanism of SARM1 to induce neuronal lossTong Wu, Jian Zhu, Amy Strickland, et al.
Nature Genetics|October 30, 2012
Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease modelsMaria Armakola, Matthew J Higgins, Matthew D Figley, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Neurobiology|April 21, 2020
The SARM1 axon degeneration pathway: control of the NAD<sup>+</sup> metabolome regulates axon survival in health and diseaseMatthew D Figley, Aaron DiAntonio
Rare Diseases (Austin, Tex.)|July 9, 2014
Yeast genetic screen reveals novel therapeutic strategy for ALSMatthew D Figley, Aaron D Gitler
Current Biology : CB|August 22, 2015
Neurodegeneration: A Leg Up on TDP-43Matthew D Figley, Aaron D Gitler
Frontiers in Immunology|October 11, 2021
The SARM1 TIR NADase: Mechanistic Similarities to Bacterial Phage Defense and Toxin-Antitoxin SystemsAaron DiAntonio, Jeffrey Milbrandt, Matthew D Figley
Neurobiology of Aging|November 26, 2013
Evaluating noncoding nucleotide repeat expansions in amyotrophic lateral sclerosisMatthew D Figley, Anna Thomas, Aaron D Gitler
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 13, 2014
Profilin 1 associates with stress granules and ALS-linked mutations alter stress granule dynamicsMatthew D Figley, Gregor Bieri, Regina-Maria Kolaitis, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2021
Multiple domain interfaces mediate SARM1 autoinhibitionChen Shen, Mihir Vohra, Pengfei Zhang, et al.
Experimental Neurology|February 23, 2020
cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axonsYo Sasaki, Thomas M Engber, Robert O Hughes, et al.
Cell Reports|October 23, 2021
Neurotoxins subvert the allosteric activation mechanism of SARM1 to induce neuronal lossTong Wu, Jian Zhu, Amy Strickland, et al.
Nature Genetics|October 30, 2012
Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease modelsMaria Armakola, Matthew J Higgins, Matthew D Figley, et al.
Pageof 2